By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – ChipDx today said that it plans to file for US regulatory approval of its test for breast cancer recurrence.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: global genetic diversity map, and more.
The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.
In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."
Stat News reports that there's muted opposition to the Kuwaiti DNA database law.